Quarterly Result13 Aug 2026, 09:01 pm
Kilitch Drugs India Declares Q1 FY27 Unaudited Results
AI Summary
Kilitch Drugs India Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated results during a meeting held on August 13, 2026. The company operates predominantly in the Pharmaceuticals sector, with no separate reporting segments as per Ind-AS108. The results were reviewed by the Audit Committee and approved by the Board.
Key Highlights
- Company declared unaudited financial results for Q1 FY27.
- Results were approved by the Board of Directors on August 13, 2026.
- Both standalone and consolidated results were presented.
- The company operates in the Pharmaceuticals sector.
- Limited Review Report by Auditors is enclosed.
Price Impact
More from KILITCH